OncoTRACE is a monitoring blood test based on the cell-free circulating tumour DNA. This is the only personalized liquid biopsy test on the market.

During the solid tumour DNA sequencing, we identify a dozen specific markers creating a unique and personalized profile that can then be traced in the patient's blood.

This non-invasive and practical technique makes it possible to quickly detect the appearance of resistances to treatment and relapses earlier than with classical medical imagery.

If you need any further information, please contact support@oncodna.com 



Did this answer your question?